Pressure Injury Prevention versus Treatment

PRESSURE CARE AND PATIENT HANDLING SPECIALISTS

Pressure Injury Prevention versus Treatment

We are regularly involved in discussions with clinicians and purchasing managers who may have conflicting priorities on asset spend and purchasing.

An understanding of the financial impact that pressure injuries have on the Australian healthcare system has been recognised in the National Safety and Quality Health Service (NSQHS) Standards – Standard 8 Preventing and Managing Pressure Injuries. Download a copy of this Standard for full details.

So how do we look at an asset that is used to prevent or treat a pressure injury? Is it seen as a cost to the business or is it an expenditure that will reduce the need for further cost?

Recent clinical studies in  Australia and overseas have demonstrated that a focus on pressure injury prevention will provide overall business cost savings. This is seen by prevention cost (in hospital) of $54.66 per day versus treatment costs of $2,770.54 per day for a Stage I/II pressure injury. Per day estimates for a Stage III/IV are between $4,779.53-$6,466.43 (Reference: NPUAP)

A Monash University study has shown that the HAPU prevalence rate has reduced from 12.5 to 2.5 over 8 years after implementing a risk assessment & intervention checklist, accurate pressure injury assessment scoring and use of prevention strategies. (Reference: Implementation of pressure ulcer prevention best practice recommendations in acute care: an observational study; Dr A Barker)

Novis Healthcare has completed many product audits in both hospitals and residential aged care which have highlighted that ease of use of a pressure mattress is a key consideration in the usage and purchasing decision.

After completing product development for the last 18 months, Novis is launching the Novis ProCair and ProCair Plus alternating pressure mattresses. Both of these mattresses have auto weight sensing to address the requirement of ease of use, while delivering superior comfort and therapeutic effect.

Contact Radley Woodhouse (radley.woodhouse@novis.com.au) for more information, or learn more about our new products in the ProCair range.